Preventive And Therapeutic Effects Of Mineralocorticoid Receptor Antagonists Pretreatment On Contrast-induced Acute Kidney Injury in Patients Undergoing Coronary Angioplasty | ||
| Benha Medical Journal | ||
| Articles in Press, Accepted Manuscript, Available Online from 13 December 2022 PDF (453.17 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/bmfj.2022.99410.1493 | ||
| Authors | ||
| Mohamed E Ibrahim1; El Metwally Lotfy El Shahawy2; Mahmoud Abdel moneum3; Abdallah Hassan* 4; Ahmed E Mansour5 | ||
| 1Internal medicine department, faculty of medicine, Benha university, Benha, Egypt | ||
| 2Internal Medicine Faculty of Medicine Banha University | ||
| 3Assist. Professor of cardiology Faculty of medicine - Benha University | ||
| 4MBBCH | ||
| 5benha university faculty of medicine internal medicine department | ||
| Abstract | ||
| Background: Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures and results from administration of iodinated contrast media (CM). Aim: was to study the preventive and the therapeutic effects of Mineralocorticoid receptor antagonist’s pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty. Methods: This case control study was carried out on patients admitted for coronary angioplasty in Benha University Hospitals(cardiology department), in which 100 patients were selected and divided in two groups “active &control” Group (A)(control): received placebo. Group (B) (Active): received Spironolactone 50 mg. Results: Blood Urea in Group (A) showed a significant increase during follow up when it was compared to baseline values while in Group (B) it showed an increase during follow up but without any statistically significant difference. Serum Creatinine in Group (A) showed a significant increase after 2 days of follow up with a mean value of 1.30±0.248 when it was compared to baseline values while in Group (B) it showed a significant increase after 2 days of follow up with a mean value of 1.15±0.406when it was compared to baseline values and also when compared to values after 7 days of follow up with a mean value of 1.19±0.384. Conclusion: The administering of Mineralocorticoid therapy prior to coronary angioplasty obtains additional benefit in terms of decrease incidence of CI-AKI in CAD patients. | ||
| Keywords | ||
| Mineralocorticoid; Contrast; Kidney; Injury; Coronary angioplasty | ||
|
Statistics Article View: 258 PDF Download: 242 |
||
